Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2006 | Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel. | Chang, CC; Liang, YC; Klutz, A; Hsu, CI; Lin, CF; Mold, DE; Chou, TC; Lee, YC; Huang, RC | Cancer chemotherapy and pharmacology 58(5), 640-653 | |||
2015 | Self-Monitoring and Self-Delivery of Photosensitizer-Doped Nanoparticles for Highly Effective Combination Cancer Therapy in Vitro and in Vivo. | Zhang, J; Liang, YC; Lin, X; Zhu, X; Yan, L; Li, S; Yang, X; Zhu, G; Rogach, AL; Yu, PK; Shi, P; Tu, LC; Chang, CC; Zhang, X; Chen, X; Zhang, W; Lee, CS | ACS nano 9(10), 9741-9756 | |||
2016 | Synthesis and Evaluation of Aminothiazole-Paeonol Derivatives as Potential Anticancer Agents. | Tsai, CY; Kapoor, M; Huang, YP; Lin, HH; Liang, YC; Lin, YL; Huang, SC; Liao, WN; Chen, JK; Huang, JS; Hsu, MH | Molecules 21(2) | |||
2005 | Systemic treatment with tetra-O-methyl nordihydroguaiaretic acid suppresses the growth of human xenograft tumors. | Park, R; Chang, CC; Liang, YC; Chung, Y; Henry, RA; Lin, E; Mold, DE; Huang, RC | Clinical cancer research : an official journal of the American Association for Cancer Research 11(12), 4601-4609 |